BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence

  Business Intelligence

New LLMs, Agents, and Graphs in Life Sciences

by BiopharmaTrend   •   Nov. 7, 2025

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook    

In recent weeks, Anthropic announced “Claude for Life Sciences” as an AI framework for assisting life science researchers. The release is one of several recent moves by general-purpose AI vendors to enter healthcare workflows.

Last year, OpenAI partnered with Formation Bio and Sanofi as well as signed agreements with Moderna, Eli Lilly; followed by a Thermo Fisher Scientific deal in 2025. At the same time xAI advertises Grok for Government with support for science and healthcare purposes, while DeepSeek gains adoption across Chinese hospitals.

Today we’ll look at LLMs entering biomedical workflows, examine what these systems can do in lab- and clinic-adjacent tasks, and how hybrid designs aim to mitigate common failure modes.


In this issue: Generative AI in Healthcare — LLMs Tailored for Life Sciences — General Models Adapted to Healthcare — Domain-Specific Biomedical LLMs — Fully Integrated Workflow Tools — Limitations & Neurosymbolic AI — Graph-Grounded LLMs — Agentic LLM Tools


 

Read this Pro article free

Subscribe to BiopharmaTrend Insider, our free biweekly briefing on what matters in tech and bio, and get one free Pro article every month, starting with this one.

See Pro plans

Insider arrives every two weeks, plus a short note when we publish a new deep dive. Unsubscribe anytime. Articles you unlock stay unlocked.

Already subscribed? Sign in here.
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook    

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.

Sign in or create an account